# The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).

> **NCT02845401** · NA · ACTIVE_NOT_RECRUITING · sponsor: **California Pacific Medical Center Research Institute** · enrollment: 121 (actual)

## Conditions studied

- Chronic Hepatitis B Virus

## Interventions

- **OTHER:** Stop NA therapy

## Key facts

- **NCT ID:** NCT02845401
- **Lead sponsor:** California Pacific Medical Center Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-11-17
- **Primary completion:** 2026-05-25
- **Final completion:** 2026-05-31
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2023-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02845401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02845401, "The Hepatitis B e-Antigen Negative Disease - Directly Offered Study of Treatment Withdrawal in Patients With e-Antigen Negative Chronic HBV Infection (BeNEG-DO).". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02845401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*